 |
|
|
Vol. 158 No. 15, August 10, 1998 |
 |
|
|
|
|
|
|
|
|
|
Review Article |
|
|
|
Dental Surgery in Anticoagulated Patients
Michael J. Wahl, DDS
Arch Intern Med. 1998;158:1610-1616.
ABSTRACT
| |
Continuous oral anticoagulant therapy has been used to decrease the risk of thromboembolism for more than half a century, prolonging the lives of thousands of patients. Many physicians recommend interrupting continuous anticoagulant therapy for dental surgery to prevent hemorrhage. In reviewing the available literature, there are no well-documented cases of serious bleeding problems from dental surgery in patients receiving therapeutic levels of continuous warfarin sodium therapy, but there were several documented cases of serious embolic complications in patients whose warfarin therapy was withdrawn for dental treatment. Many authorities state that dental extractions can be performed with minimal risk in patients who are at or above therapeutic levels of anticoagulation. There are sound legal reasons to continue therapeutic levels of warfarin for dental treatment. Although there is a theoretical risk of hemorrhage after dental surgery in patients who are at therapeutic levels of anticoagulation, the risk appears to be minimal, the bleeding usually can be easily treated with local measures, and this risk may be greatly outweighed by the risk of thromboembolism after withdrawal of anticoagulant therapy.
INTRODUCTION
Continuous oral anticoagulant therapy has been used to decrease the risk of thromboembolism for more than 50 years, prolonging the lives of thousands of patients. Dental treatment on continuously anticoagulated patients has been controversial,1-4 and physicians must weigh the risks of hemorrhage from the dental procedure against the risks of emboli from withdrawing anticoagulation treatment. Some recommend no change in anticoagulation for dental treatment.5-6 Others recommend withdrawal of oral anticoagulant therapy for several days before the procedure and consideration of therapeutic administration of heparin for certain high-risk patients and high-risk dental procedures.7-11 The focus of this article is to review only surgical dental procedures (extractions, gingival surgery, and alveolar surgery): nonsurgical dental procedures (professional cleanings, fillings, crowns, etc) have been shown not to present a significant bleeding risk.5
In a 1995 survey, the majority (73%) of practicing physicians recommended withdrawing therapeutic continuous warfarin therapy in some patients for at least some dental procedures.12 Instead of changing the patient's prothrombin time, it is time to change the practice of withdrawing anticoagulant treatment for dental surgery.
DENTAL SURGERY IN ANTICOAGULANT-TREATED PATIENTS
In a review of the English-language literature (using computerized searches and authors' references), there have been more than 2014 dental surgical procedures (including more than 1964 dental extractions) documented in 26 case reports and studies of more than 774 patients receiving continuous oral anticoagulant therapy. These procedures include both single and multiple simple extractions, surgical extractions, full mouth extractions, alveoectomies, and other surgical procedures. Nonsurgical dental procedures were not included in this review. Many of the patients had levels of warfarin above 1992 recommended levels on the day of surgery. In 1992, the American College of Chest Physicians stated that the recommended therapeutic range of warfarin is an international normalized ratio (INR) of 2.0 to 3.0 for all conditions except for patients with mechanical prosthetic valves, for which the INR is 2.5 to 3.5.13 These recommendations were endorsed by the American Heart Association.14 Assuming an international sensitivity index between 1.8 and 2.8, the therapeutic prothrombin time (PT) ratio would range from at lowest 1.3 to at highest 2.0. Cannegieter et al15 have suggested a higher therapeutic range, an INR of 3.0 to 4.0 (PT ratio  2.2), for patients with artificial valves. Therefore, for the purposes of this review, the therapeutic level of warfarin in all patients is no higher than an INR of 4.0 or a PT ratio (at highest) of 2.2. The studies of reported cases of dental surgery on patients receiving continuous oral anticoagulant therapy are summarized in Table 1.
|
|
|
|
Table 1. Reported Cases of Dental Surgery on Patients Receiving Continuous Oral Anticoagulant Therapy*
|
|
|
Because of variations in study designs and differences in measuring the intensity of anticoagulant therapy between the more recent and the older reports, these studies do not lend themselves to a conventional meta-analysis or even systematic review. Still, of the more than 2014 dental surgical procedures reported in more than 774 patients receiving continuous warfarin therapy, the following observations can be made:
- Although some patients had minor oozing treated with local measures, more than 98% of patients receiving continuous anticoagulation had no serious bleeding problems after dental surgery, with serious bleeding problems defined as bleeding uncontrolled by local measures.
- Many of these procedures were performed in patients with warfarin levels above present recommended therapeutic levels of anticoagulation.
- Many procedures were extensive, including multiple and full mouth extractions, alveoectomies, and surgical extractions.
- Only 12 patients (<2%) had postoperative bleeding problems that were controlled by more than local measures. But after examining these 12 cases closely, none makes a good case for withdrawal of warfarin for dental surgery.
ANALYSIS OF 12 DOCUMENTED CASES OF POSTOPERATIVE HEMORRHAGE TREATED BY MORE THAN LOCAL MEASURES
In 5 of the 12 cases,30, 32, 41 the PT ratios were above therapeutic levels. In 3 cases21, 39 in which patients were administered concomitant antibiotics, the preoperative INR was within the therapeutic range, and bleeding was initially controlled in all 3 cases by local measures. After 2 consecutive days (contrary to American Heart Association guidelines to prevent endocarditis44) of high-dose prophylactic erythromycin treatment, 1 of these patients developed bleeding 2 days after the extraction (when his INR was 4.3).39 Another patient had 6 extractions done after prophylactic amoxicillin was administered.39 Interestingly, although this patient's INR was an astounding 9.1 one week after the extraction, only 1 socket was bleeding, and this bleeding was only described as "oozing," indicating that the hospitalization may have been precautionary for the high INR and not for the oozing. The authors speculated that the antibiotics caused the increase in INR and subsequent bleeding and oozing, although there may have been other causes, including warfarin overdose. In the third case, the patient had a therapeutic preoperative INR of 3.51 for 20 extractions and an alveoplasty, and there was good hemostasis 72 hours postoperatively.21 Although antibiotic prophylaxis has not been shown to be necessary or effective in preventing postextraction wound infections,45 prophylaxis with amoxicillin, 500 mg 3 times daily for 7 days after surgery, had been prescribed. On the fourth postsurgical day, the patient was bleeding. The INR was then 9.03. Warfarin (Coumadin) was withheld, and the patient underwent transfusion of fresh-frozen plasma, then packed red blood cells, and ultimately vitamin K. The authors concluded that the elevated PT was from an interaction with amoxicillin, and that the amoxicillin was probably unnecessary.
Ramstrom et al31 and Sindet-Pedersen et al34 conducted separate studies comparing results of dental surgery on patients taking anticoagulants who rinsed 4 times a day for 7 days with a tranexamic acid mouthwash with those of patients who rinsed with a placebo mouthwash. Only 1 patient in each study (each in the placebo group) developed postoperative bleeding that was treated by more than local measures. Unfortunately, the authors did not report these patients' INRs, although they reported an INR range of all patients, the upper level of which in the study by Sindet-Pedersen was above recommended therapeutic levels. More important, the study design was poor: patients should not rinse at all after dental extractions until a hemostatic clot has formed.28, 46 Rinsing with a placebo mouthwash after dental extractions could have created the bleeding problem by interrupting the formation of a hemostatic clot. A more fair comparison would have been comparing tranexamic acid with no mouthwash at all.
Kwapis28 reported in 1963 that 3 of 60 treated patients had "prolonged bleeding" after dental extractions. The PT ratio was reported for only 2 of these patients, and it was less than 1.5. These patients were administered vitamin K, but it was not reported if local measures to control hemostasis were attempted before administering vitamin K.
Although there is a theoretical risk of hemorrhage after dental surgery, the literature indicates that the risk is very small. Some investigators recommend consideration of replacement heparin for especially high-risk patients undergoing extensive dental surgery. In addition to the high cost-benefit ratio for intravenous administration of heparin,47 the cases documented above include many extensive surgical procedures and argue against any withdrawal of anticoagulant therapy, including heparin replacement. In reviewing the English-language literature, there are no well-documented cases of serious bleeding problems from dental surgery in patients receiving therapeutic levels of continuous anticoagulant therapy.
DENTAL TREATMENT IN PATIENTS DURING WITHDRAWAL OF CONTINUOUS ANTICOAGULATION
Many practitioners believe that there is minimal risk of thromboembolism in patients whose anticoagulant therapy is interrupted for surgery.48 Warfarin withdrawal may49 or may not50 create a transient hypercoagulable state, but if warfarin prevents thromboembolism, then withdrawal of warfarin does not prevent thromboembolism. There have been several documented cases of serious embolic complications, including deaths, after withdrawing continuous warfarin therapy. Cosgriff51 reported that embolisms occurred in 14 of 17 patients (71% of cases) whose warfarin therapy was withdrawn. Three of these embolisms occurred within 5 days of the interruption of therapy.
In 542 documented cases in 493 patients of withdrawing continuous anticoagulation specifically for dental procedures, 5 (1.0% of patients; 0.9% of cases) had serious embolic complications (including 4 deaths). Table 2 presents the reported cases of withdrawal of continuous oral anticoagulation for dental procedures (patients receiving heparin replacement are not included).
|
|
|
|
Table 2. Reported Cases of Withdrawal of Continuous Oral Anticoagulation for Dental Procedures*
|
|
|
Unfortunately, there are several documented cases of serious embolic complications in patients whose warfarin therapy has been withdrawn for dental treatment.
There are limitations in comparing the results of dental surgery in patients receiving continuous anticoagulant therapy with those of patients whose anticoagulation treatment is withdrawn. There was not necessarily a direct cause-and-effect relationship between the embolic complications and the withdrawal of warfarin therapy for dental treatment since these complications sometimes occur even if the patient continues warfarin therapy. On the other hand, some of the bleeding complications in patients who continued warfarin therapy for dental surgery may have also been coincidental since patients who have normal coagulation sometimes have postoperative bleeding.
Several studies have confirmed that warfarin therapy should not be interrupted for nonsurgical dental procedures.5, 11, 57, 61 On the other hand, a single dental extraction has been called "a significant stress to the hemostatic mechanisms."62 Some recommend that anticoagulation therapy be reduced or withdrawn until PT or INR is near normal (PT within 1.5 times control)63-64 or even normal65 before dental surgery.
At a minimum, the application of pressure is required immediately after dental extractions, especially in patients receiving anticoagulant therapy. But dental extractions are different from other types of surgery: major vessels are unlikely to be encountered, and postoperative bleeding is usually controlled within minutes by application of pressure (biting on gauze) or, if necessary, additional local measures such as biting on tea bags (which contain tannic acid) or using gelatin sponges, topical thrombin, additional sutures, and even electrocautery. The American Dental Association has stated that for dental treatment, postoperative bleeding is minimal if the PT is close to (or even slightly above, depending on the international sensitivity index) the therapeutic range (PT up to 2 times the control).66 Several investigators have stated that postoperative bleeding after dental extractions is minimal at or above present therapeutic PT ratios (PT up to 2.5 times the control).5, 67-68
Since dental extractions have been called a "significant" or even "severe" challenge to hemostasis, some assume that dental extractions in anticoagulant-treated patients present more bleeding problems than in patients not taking anticoagulants. But even patients with normal coagulation undergoing dental surgery may have postoperative hemorrhage. Several studies have compared postoperative bleeding in anticoagulant-treated patients with that of normally coagulated patients. McIntyre30 compared postoperative bleeding after dental extractions in 106 anticoagulant-treated patients with that of 106 normally coagulated patients and found no difference in postoperative bleeding. Greenberg et al26 compared blood loss after dental extractions in 13 patients receiving continuous warfarin anticoagulation with that of 7 control patients. Only 2 anticoagulant-treated patients had significantly greater blood loss per tooth than the control group (in both cases the bleeding was controlled by local measures). Bailey and Fordyce20 compared the result of extractions in 25 anticoagulant-treated patients with that of 25 control patients and found no difference in immediate postoperative bleeding. There was more "late bleeding" in the anticoagulated group, which was "easily controlled" by local measures.
Even if practicing physicians and dentists are convinced that there are sound scientific and medical reasons to continue therapeutic levels of warfarin for dental surgery, they may decide to interrupt therapy for fear of a lawsuit after complications from postoperative hemorrhage in a patient whose INR was not lowered to below the therapeutic range before dental surgery. These practitioners are actually treating the doctor rather than the patient. The leading cause of lawsuits against physicians is improper prescribing of medications,69 which may include altering therapeutic levels of anticoagulants. Although theoretically possible, there are no well-documented cases of serious postoperative bleeding complications after dental surgery in patients receiving anticoagulant therapy within the therapeutic range. If a patient whose preoperative PT ratio or INR was within the therapeutic range were to be hospitalized or even die of postoperative hemorrhage after dental surgery, the defendant can show that many authorities state that there is minimal risk of such hemorrhage during dental procedures within the therapeutic range, while pointing out the risks of thromboembolism if therapy is interrupted. On the other hand, if a patient whose warfarin dosage was reduced or withdrawn below therapeutic levels has serious complications or dies of an embolism, the plaintiff can use these same studies to reject the interruption of therapy. In either case, there are good legal reasons to continue warfarin therapy for dental surgery.
CONCLUSIONS
It is time to stop interrupting warfarin therapy for dental surgery. Although there is a theoretical risk of hemorrhage after dental surgery in patients at therapeutic levels of anticoagulation, the risk is minimal, bleeding is usually easily treated with local measures, and the risk may be greatly outweighed by the risk and morbidity of thromboembolism after withdrawal of anticoagulant therapy. There are no well-documented cases of serious bleeding problems from dental surgery in patients receiving therapeutic levels of continuous warfarin therapy. There are several documented cases of serious embolic complications, including deaths, in patients whose warfarin therapy has been withdrawn for dental treatment. Many authorities state that dental extractions can be performed with minimal risk at or above therapeutic levels of anticoagulation. Patients receiving anticoagulant therapy who undergo dental surgery have not been shown to have more bleeding problems than patients with normal coagulation. There are sound legal reasons to continue therapeutic levels of warfarin for dental treatment. Dentists and physicians should collaborate closely in treating their patients who are taking anticoagulants, especially to make sure that the patient's INR is within the therapeutic range before dental surgery. Good surgical technique and local measures to control bleeding are important in all dental surgical patients, especially those receiving continuous anticoagulation.
AUTHOR INFORMATION
Accepted for publication January 15, 1998.
Reprints: Michael J. Wahl, DDS, 1601 Concord Pike, Wilmington, DE 19803.
From the Department of Dentistry, Christiana Care Health Services, Wilmington, Del.
REFERENCES
| |
1. Herman WW, Konzelman JL, Sutley SH. Current perspectives on dental patients receiving coumarin anticoagulant therapy. J Am Dent Assoc. 1997;128:327-335.
FREE FULL TEXT
2. Bierne OR, Koehler JR. Surgical management of patients on warfarin sodium. J Oral Maxillofac Surg. 1996;54:1115-1118.
FULL TEXT
|
ISI
| PUBMED
3. Weibert RT. Oral anticoagulant therapy in patients undergoing dental surgery. Clin Pharm. 1992;11:857-864.
ISI
| PUBMED
4. Butchart EG. Anticoagulation management during non-cardiac surgery: time for common sense. J Heart Valve Dis. 1994;3:313-314.
PUBMED
5. Benoliel R, Leviner E, Katz J, Tzukert A. Dental treatment for the patient on anticoagulant therapy: prothrombin time value—what difference does it make? Oral Surg Oral Med Oral Pathol. 1986;62:149-151.
FULL TEXT
|
ISI
| PUBMED
6. Askey JM, Cherry CB. Dental extraction during dicumarol therapy. Calif Med. 1956;84:16-17.
PUBMED
7. Pavek V, Bigl P. Stomatological treatment of patients with artificial heart valves: coagulation control and antibiotic cover. Int Dent J. 1993;43:59-61.
PUBMED
8. Patton LL, Ship JA. Treatment of patients with bleeding disorders. Dent Clin North Am. 1994;38:465-482.
PUBMED
9. Carr MM, Mason RB. Dental management of anticoagulated patients. Can Dent Assoc J. 1992;58:838-844.
10. Roser SM, Rosenbloom B. Continued anticoagulation in oral surgery procedures. Oral Surg Oral Med Oral Pathol. 1975;40:448-457.
FULL TEXT
|
ISI
| PUBMED
11. Mulligan R, Weitzel KG. Pretreatment management of the patient receiving anticoagulant drugs. J Am Dent Assoc. 1988;117:479-483.
ABSTRACT
12. Wahl MJ, Howell J. Altering anticoagulation therapy: a survey of physicians. J Am Dent Assoc. 1996;127:625-638.
FREE FULL TEXT
13. Hirsh J, Dalen JE, Deykin D, Poller L. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 1992;102(suppl):312S-326S.
14. Hirsh J, Fuster V. Guide to anticoagulant therapy, part 2: oral anticoagulants. Circulation. 1994;89:1469-1480.
FREE FULL TEXT
15. Cannegieter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med. 1995;333:11-17.
FREE FULL TEXT
16. Le DT, Weibert RT, Sevilla BK, Donnelly KJ, Rapaport SI. The international normalized ratio (INR) for monitoring warfarin therapy: reliability and relation to other monitoring methods. Ann Intern Med. 1994;120:552-558.
FREE FULL TEXT
17. Hirsh J, Deykin D, Poller L. "Therapeutic range" for oral anticoagulant therapy. Chest. 1986;89(suppl):11S-15S.
18. Hirsch J, Poller L. The international normalized ratio: a guide to understanding and correcting its problems. Arch Intern Med. 1994;154:282-288.
FREE FULL TEXT
19. Anavi Y, Sharon A, Gutman D, Laufer D. Dental extractions during anticoagulant therapy. Isr J Dent Med. 1981;28(4):9-12.
20. Bailey BMW, Fordyce AM. Complications of dental extractions in patients receiving warfarin anticoagulant therapy: a controlled clinical trial. Br Dent J. 1983;155:308-310.
FULL TEXT
|
ISI
| PUBMED
21. Bandrowsky T, Vorono AA, Borris TJ, Marcantoni HW. Amoxicillin-related postextraction bleeding in an anticoagulated patient with tranexamic acid rinses. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;82:610-612.
FULL TEXT
|
ISI
| PUBMED
22. Behrman SJ, Wright IS. Dental surgery during continuous anticoagulant therapy. J Am Dent Assoc. 1961;62:172-180.
23. Borea G, Montebugnoli L, Capuzzi P, Magelli C. Tranexamic acid as a mouthwash in anticoagulant-treated patients undergoing oral surgery: an alternative method to discontinuing anticoagulant therapy. Oral Surg Oral Med Oral Pathol. 1993;75:29-31.
FULL TEXT
|
ISI
| PUBMED
24. Cone A. Dental abscess in an anticoagulated patient with ankylosing spondylitis. Br J Hosp Med. 1993;49:190.
ISI
| PUBMED
25. Frank BW, Dickhaus DW, Claus EC. Dental extractions in the presence of continual anticoagulant therapy. Ann Intern Med. 1963;59:911-913.
26. Greenberg MS, Miller MF, Lynch MA. Partial thromboplastin time as a predictor of blood loss in oral surgery patients receiving coumarin anticoagulants. J Am Dent Assoc. 1972;84:583-587.
ISI
| PUBMED
27. Kovacs B, Toth K, Kerenyi G. Post-extraction hemostasis during coumarin anticoagulant therapy with a locally applied coagulation-active substance. Int J Oral Surg. 1976;5:3-7.
ISI
| PUBMED
28. Kwapis BW. Anticoagulant therapy and dental practice. J Am Dent Assoc. 1963;66:172-175.
29. Martinowitz U, Mazar AL, Taicher S, et al. Dental extraction for patients on oral anticoagulant therapy. Oral Surg Oral Med Oral Pathol. 1990;70:274-277.
FULL TEXT
|
ISI
| PUBMED
30. McIntyre H. Management, during dental surgery, of patients on anticoagulants. Lancet. 1966;2:99-100.
ISI
| PUBMED
31. Ramstrom G, Sindet-Pedersen S, Hall G, Blomback M, Alander U. Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants. J Oral Maxillofac Surg. 1993;51:1211-1216.
ISI
| PUBMED
32. Shira RB, Hall RJ, Guernsey LH. Minor oral surgery during prolonged anticoagulant therapy. J Oral Surg. 1962;20:93-99.
PUBMED
33. Souto JC, Oliver A, Zuazu-Jausoro I, Vives A, Fontcuberta J. Oral surgery in anticoagulated patients without reducing the dose of oral anticoagulant: a prospective randomized study. J Oral Maxillofac Surg. 1996;54:27-32.
FULL TEXT
|
ISI
| PUBMED
34. Sindet-Pedersen S, Ramstrom G, Bernvil S, Blomback M. Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. N Engl J Med. 1989;320:840-843.
ABSTRACT
35. Street AM, Leung W. Use of tranexamic acid mouthwash in dental procedures in patients taking oral anticoagulants. Med J Aust. 1990;153:630.
36. Tomasi NJ, Wolf JE. Presurgical management of a patient receiving anticoagulant therapy: report of case. J Am Dent Assoc. 1974;88:1028-1029.
ISI
| PUBMED
37. Tulloch J, Wright IS. Long-term anticoagulant therapy: further experiences. Circulation. 1954;9:823-834.
ISI
| PUBMED
38. Waldrep AC, McKelvey LE. Oral surgery for patients on anticoagulant therapy. J Oral Surg. 1968;26:374-380.
FULL TEXT
|
ISI
| PUBMED
39. Wood GD, Deeble T. Warfarin: dangers with antibiotics. Dent Update. 1993;20:350-353.
PUBMED
40. Yoshimura Y, Oka M, Kishimoto H, Matsuura R, Mishima K. Hemodynamic changes during dental extraction and post-extraction bleeding in patients with prosthetic heart valves. Int J Oral Maxillofac Surg. 1987;16:425-431.
FULL TEXT
|
ISI
| PUBMED
41. Ziffer AM, Scopp IW, Beck J, Baum J, Berger AR. Profound bleeding after dental extractions during dicumarol therapy. N Engl J Med. 1957;256:351-353.
42. Scopp IW, Fredrics H. Dental extractions in patients undergoing anticoagulant therapy. Oral Surg Oral Med Oral Pathol. 1958;11:470-474.
FULL TEXT
| PUBMED
43. Zusman SP, Lustig JP, Baston I. Postextraction hemostasis in patients on anticoagulant therapy: the use of a fibrin sealant. Quintessence Int. 1992;23:713-716.
PUBMED
44. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA. 1997;277:1794-1801.
FREE FULL TEXT
45. Antimicrobial prophylaxis in surgery. Med Lett. 1995;37:79-82.
46. Postoperative instructions. In: Peterson LJ, Ellis E, Hupp JR, Tucker MR, eds. Contemporary Oral and Maxillofacial Surgery. 2nd ed. St Louis, Mo: Mosby–Year Book Inc; 1993:772.
47. Eckman MH, Beshansky JR, Durand-Zaleski I, Levine HJ, Pauker SG. Anticoagulation for noncardiac procedures in patients with prosthetic heart valves: does low risk mean high cost? JAMA. 1990;263:1513-1521.
FREE FULL TEXT
48. Tinker JH, Tarhan S. Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses: observations in 180 operations. JAMA. 1978;239:738-739.
FREE FULL TEXT
49. Grip L, Blomback M, Schulman S. Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial infarction patients. Eur Heart J. 1991;12:1225-1233.
FREE FULL TEXT
50. Michaels L, Beamish RE. Relapses of thromboembolic disease after discontinued anticoagulant therapy: a comparison of the incidence after abrupt and after gradual termination of treatment. Am J Cardiol. 1967;20:670-673.
FULL TEXT
|
ISI
| PUBMED
51. Cosgriff SW. Chronic anticoagulant therapy in recurrent embolism of cardiac origin. Ann Intern Med. 1953;38:278-287.
52. Akbarian M, Austen WG, Yurchak PM, Scannell JG. Thromboembolic complications of prosthetic cardiac valves. Circulation. 1968;37:826-831.
FREE FULL TEXT
53. Davis FB, Sczupak CA. Outpatient oral anticoagulation: guidelines for long-term management. Postgrad Med. 1979;66:100-109.
54. Marshall J. Rebound phenomena after anticoagulant therapy in cerebrovascular disease. Circulation. 1963;28:329-332.
FREE FULL TEXT
55. Mulligan R. Response to anticoagulant drug withdrawal. J Am Dent Assoc. 1987;115:435-438.
ABSTRACT
56. Ogiuchi H, Ando T, Tanaka M, et al. Clinical reports on dental extraction from patients undergoing oral anticoagulant therapy. Bull Tokyo Dent Coll. 1985;26:205-212.
PUBMED
57. Saour JN, Ali HA, Mammo LARF, Sieck JO. Dental procedures in patients receiving oral anticoagulation therapy. J Heart Valve Dis. 1994;3:315-317.
PUBMED
58. Sheller B, Tong D. Dental management of a child on anticoagulant therapy and the International Normalized Ratio: case report. Pediatr Dent. 1994;16:56-58.
PUBMED
59. Wood JC, Conn HL. Prevention of systemic arterial embolism in chronic rheumatic heart disease by means of protracted anticoagulant therapy. Circulation. 1954;10:517-523.
ISI
| PUBMED
60. Zusman SP, Lustig JP, Nun GB. Cost evaluation of two methods of post tooth extraction hemostasis in patients on anticoagulant therapy. Community Dent Health. 1993;10:167-173.
PUBMED
61. Rooney TP. General dentistry during continuous anticoagulation therapy. Oral Surg Oral Med Oral Pathol. 1983;56:252-255.
FULL TEXT
|
ISI
| PUBMED
62. Catalano PM. Introduction to hemostasis. In: Rose LF, Kaye D, eds. Internal Medicine for Dentistry. 2nd ed. St Louis, Mo: Mosby–Year Book Inc; 1990:346.
63. Peterson LJ. Prevention and management of surgical complications. In: Peterson LJ, Ellis E, Hupp JR, Tucker MR, eds. Contemporary Oral and Maxillofacial Surgery. 2nd ed. St Louis, Mo: Mosby– Year Book Inc; 1993:269-288.
64. Bleeding disorders. In: Sonis ST, Fazio RC, Fang L. Principles and Practice of Oral Medicine. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1995:242-261.
65. Dugdale M, Smith RM. The patient with bleeding problems. Dent Clin North Am. 1983;27:271-288.
ISI
| PUBMED
66. Disorders of hemostasis. In: Accepted Dental Therapeutics. 40th ed. Chicago, Ill: American Dental Association; 1984:39-40.
67. Little JW, Falace DA. Bleeding disorders. In: Dental Management of the Medically Compromised Patient. 5th ed. St Louis, Mo: Mosby–Year Book Inc; 1997:466-494.
68. Cohen SG, Glick M. Anticoagulant therapy. In: Rose LF, Kaye D, eds. Internal Medicine for Dentistry. 2nd ed. St Louis, Mo: Mosby–Year Book Inc; 1990:374.
69. Physicians Insurers Association of America report: top ten reasons for malpractice suits. Wilmington, Del. Sunday News Journal. November 22, 1992:A15.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTERS
Anticoagulated Patients and Oral Surgery
David W. Todd
Arch Intern Med. 2003;163(10):1242.
EXTRACT
| FULL TEXT
Warfarin Therapy Adjustment for Oral Surgery Is an Unnecessary Risk
Duncan Bayne and Peter A. Brennan
Arch Intern Med. 2008;168(17):1932.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Coagulation Concepts Update
O'Connor et al.
Am. J. Roentgenol. 2009;193:1656-1664.
ABSTRACT
| FULL TEXT
Standardized Low-Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery: An Inception Cohort Management Study
Pengo et al.
Circulation 2009;119:2920-2927.
ABSTRACT
| FULL TEXT
Atrial Fibrillation: Pathogenesis, Medical-Surgical Management and Dental Implications
Friedlander et al.
Journal of the American Dental Association 2009;140:167-177.
ABSTRACT
| FULL TEXT
Warfarin Therapy Adjustment for Oral Surgery Is an Unnecessary Risk
Bayne and Brennan
Arch Intern Med 2008;168:1932-1932.
FULL TEXT
Factors in Warfarin Therapy Discontinuation--Reply
Garcia and Hylek
Arch Intern Med 2008;168:1933-1933.
FULL TEXT
Aspirin Use and Post-operative Bleeding from Dental Extractions
Brennan et al.
JDR 2008;87:740-744.
ABSTRACT
| FULL TEXT
Utility of an International Normalized Ratio Testing Device in a Hospital-Based Dental Practice
Brennan et al.
Journal of the American Dental Association 2008;139:697-703.
ABSTRACT
| FULL TEXT
Improvement in Medical Consultation Responses with a Structured Request Form
Geist and Geist
J Dent Educ 2008;72:553-561.
ABSTRACT
| FULL TEXT
Educational Practices Regarding Anticoagulation and Dental Procedures in U.S. Dental Schools
Linnebur et al.
J Dent Educ 2007;71:296-303.
ABSTRACT
| FULL TEXT
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology
Authors/Task Force Members et al.
Eur Heart J 2007;0:ehl428v1-39.
FULL TEXT
Hemostatic Mouthwashes in Anticoagulated Patients Undergoing Dental Extraction
Patatanian and Fugate
The Annals of Pharmacotherapy 2006;40:2205-2210.
ABSTRACT
| FULL TEXT
Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery.
Dayani and Grand
Arch Ophthalmol 2006;124:1558-1565.
ABSTRACT
| FULL TEXT
Post-operative use of heparin increases morbidity of pacemaker implantation.
Marquie et al.
Europace 2006;8:283-287.
ABSTRACT
| FULL TEXT
Recommendations for the management of patients after heart valve surgery
Butchart et al.
Eur Heart J 2005;26:2463-2471.
ABSTRACT
| FULL TEXT
Perioperative Management of Patients on Oral Anticoagulants: A Decision Analysis
Dunn et al.
Med Decis Making 2005;25:387-397.
ABSTRACT
The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Ansell et al.
Chest 2004;126:204S-233S.
ABSTRACT
| FULL TEXT
Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin: Assessment of a Standardized Periprocedural Anticoagulation Regimen
Douketis et al.
Arch Intern Med 2004;164:1319-1326.
ABSTRACT
| FULL TEXT
Stopping Warfarin Therapy is Unnecessary for Hand Surgery
WALLACE et al.
J Hand Surg Eur Vol 2004;29:201-203.
ABSTRACT
| FULL TEXT
Lack of a scientific basis for routine discontinuation of oral anticoagulation therapy before dental treatment
JESKE and SUCHKO
Journal of the American Dental Association 2003;134:1492-1497.
ABSTRACT
| FULL TEXT
Continuation of Medically Necessary Aspirin and Warfarin During Cutaneous Surgery
Otley
Mayo Clin Proc. 2003;78:1392-1396.
ABSTRACT
Anticoagulated Patients and Oral Surgery
Todd
Arch Intern Med 2003;163:1242-1242.
FULL TEXT
The complexities involved with managing the care of an elderly patient
LINDQUIST and ETTINGER
Journal of the American Dental Association 2003;134:593-600.
ABSTRACT
| FULL TEXT
Perioperative Management of Patients Receiving Oral Anticoagulants: A Systematic Review
Dunn and Turpie
Arch Intern Med 2003;163:901-908.
ABSTRACT
| FULL TEXT
Thrombotic Disorders: Diagnosis and Treatment
Schafer et al.
ASH Education Book 2003;2003:520-539.
ABSTRACT
| FULL TEXT
The use of low-molecular-weight heparins in outpatient oral surgery for patients receiving anticoagulation therapy
JOHNSON-LEONG and RADA
Journal of the American Dental Association 2002;133:1083-1087.
ABSTRACT
| FULL TEXT
Managing Oral Anticoagulant Therapy
Ansell et al.
Chest 2001;119
:22S-38S.
FULL TEXT
VALVE DISEASE: Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery
Gohlke-Bärwolf
Heart 2000;84:567-572.
FULL TEXT
Simple and Safe Method to Prepare Patients With Prosthetic Heart Valves for Surgical Dental Procedures
Russo et al.
CLIN APPL THROMB HEMOST 2000;6:90-93.
ABSTRACT
MYTHS OF DENTAL SURGERY IN PATIENTS: RECEIVING ANTICOAGULANT THERAPY
WAHL
Journal of the American Dental Association 2000;131:77-81.
ABSTRACT
| FULL TEXT
A Stuck PigEven on WarfarinDoesn't Always Bleed
Kitchens
Chest 1999;115:1492-1493.
FULL TEXT
|
|
|
